Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome.

Peng L, Ding H, Yang M, Cheng Y, Luo X, Fan X, Jiao W

Open source

DOI
10.1155/2022/9377334
Published
2022
Container
Evidence-based complementary and alternative medicine : eCAM
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/9377334,
  title = {Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome.},
  author = {Peng L and Ding H and Yang M and Cheng Y and Luo X and Fan X and Jiao W},
  year = {2022},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  doi = {10.1155/2022/9377334},
  url = {https://doi.org/10.1155/2022/9377334}
}

RIS

TY  - JOUR
TI  - Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome.
AU  - Peng L
AU  - Ding H
AU  - Yang M
AU  - Cheng Y
AU  - Luo X
AU  - Fan X
AU  - Jiao W
PY  - 2022
JO  - Evidence-based complementary and alternative medicine : eCAM
DO  - 10.1155/2022/9377334
UR  - https://doi.org/10.1155/2022/9377334
ER  - 

APA

L, P., H, D., M, Y., Y, C., X, L., X, F., & W, J. (2022). Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2022/9377334

Source records